as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High

3.33%
Downside
2.39%
Upside

52 Week's Low
52 Week's High

70.62%
Downside
13.83%
Upside

Check Personalis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$846.9M
EPS (TTM)
-0.965
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.78
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-61.6M
Revenue (TTM)
80.3M
Profit Margin
-113.70%
Return On Equity TTM
-60.26%
Track how Personalis Inc P/E has moved over time to understand its valuation trends.
Personalis Inc in the last 5 years
Lowest (-28.81x)
March 31, 2021
Today (-3.78x)
October 31, 2025
Industry (-0.81x)
October 31, 2025
Highest (-0.61x)
December 31, 2023
Today’s Price to Earnings Ratio: -3.78x
Compare market cap, revenue, PE, and other key metrics of Personalis Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $846.9M | -61.54% | -3.78 | -113.70% | |
| BUY | $50.2B | 47.95% | 52.09 | 24.41% | |
| BUY | $210.8B | 17.56% | 32.25 | 15.02% | |
| BUY | $40.6B | 40.43% | 33.5 | 17.97% | |
| BUY | $36.9B | 40.57% | 29.73 | 8.07% | 
The Personalis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Personalis Inc investment value today
Current value as on today
₹1,96,137
Returns
₹96,137
(+96.14%)
Returns from Personalis Inc Stock
₹90,495 (+90.5%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Personalis Inc. Average target price of $8.06
Get share price movements and forecasts by analysts on Personalis Inc.
What analysts predicted
-19.35%DOWNSIDE
Target Price
$8.06
Current Price
$9.62
Analyzed by
12 Analysts
Target
$8.06
Personalis Inc target price $8.06, a slight downside of -19.35% compared to current price of $9.62. According to 12 analysts rating.
Search interest for Personalis Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 1 month, PSNL stock has moved up by 45.9%
 POSITIVE IMPACT
POSITIVE IMPACTBest in 3 Years

In the last 3 years, PSNL has outperformed top 5 stocks with highest market-cap in its industry
 POSITIVE IMPACT
POSITIVE IMPACTBest in 1 Year

In the last 1 year, PSNL has outperformed top 5 stocks with highest market-cap in its industry
 NEGATIVE IMPACT
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 2 quarters, 20.60M → 17.20M (in $), with an average decrease of 16.5% per quarter
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, -15.75M → -20.05M (in $), with an average decrease of 27.3% per quarter
| Organisation | Personalis Inc | 
| Headquarters | 6600 Dumbarton Circle, Fremont, CA, United States, 94555 | 
| Industry | Biotechnology | 
| CEO | Mr. Christopher M. Hall | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Mr. Aaron L. Tachibana | CFO & COO | 
| Dr. Russ B. Altman M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | 
| Dr. Michael P. Snyder Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | 
| Mr. Ashish Kheterpal | Senior VP & Chief Information Officer | 
| Dr. Christian Haudenschild Ph.D. | Senior Vice President of Genomic Science | 
| Mr. Stephane Mouradian Ph.D. | Senior Vice President of Business Development | 
| Mr. Christopher M. Hall | President, CEO & Director | 
| Dr. Richard Chen M.D., M.S. | Executive VP of R&D and Chief Medical Officer | 
| Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | 
| Mr. Stephen M. Moore J.D. | Senior VP, Chief Legal Officer & Corporate Secretary | 
Personalis Inc share price today is $9.62 as on at the close of the market. Personalis Inc share today touched a day high of $9.85 and a low of $9.3.
Personalis Inc share touched a 52 week high of $10.95 on and a 52 week low of $2.83 on . Personalis Inc stock price today i.e. is closed at $9.62,which is 12.15% down from its 52 week high and 240.39% up from its 52 week low.
Personalis Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Personalis Inc (PSNL) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Personalis Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Personalis Inc share’s latest price of $9.62 as on November 1, 2025 at 1:29 am IST, you will get 1.0395 shares of Personalis Inc. Learn more about
          
            fractional shares .
        
Personalis Inc stock has given -61.54% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?